GLP-1 and FGF21 double-factor high-expression adipose-derived stem cell target gene copy number detection method
By using WPRE sequence and ALB gene combined with qPCR technology in diabetic cell therapy, the problem of safety and effectiveness evaluation of GLP-1 and FGF21 bifactor modified cell therapy in the prior art was solved, and high-specificity and repetition were achieved Sex testing ensures the safety and effectiveness of cell therapy products.
Patent Information
- Application Number
- CN202410676730.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-05-29
- Filing Date
- 2024-05-29
- Publication Date
- 2024-11-29
AI Technical Summary
The existing treatment methods for diabetes cell are single and ineffective, and lack the safety, effectiveness and stability assessment methods for the two-factor modification of autologous adipose mesenchymal stem cells.
The WPRE sequence was used as the detection site of the target gene and the ALB gene was used as the internal reference gene, combined with qPCR technology and Taqman probe method, quantitative detection of the gene copy number of the target gene in GLP-1 and FGF21 bifactor high-expression adipose stem cells was performed.
Highly specialized and repetitive detection of gene copy number of GLP-1 and FGF21 bifactor high-expression adipose stem cells was achieved, ensuring the safety and effectiveness evaluation of cell therapy products.
Smart Images

Figure SMS_1 
Figure SMS_2 
Figure SMS_3
Abstract
Description
Technical Field
[0001] The present invention relates to a method for detecting the copy number of a target gene in a gene-modified cell, and in particular to a method for detecting the copy number of a target gene in adipose stem cells with high expression of GLP-1 and FGF21 dual factors. Background Art
[0002] In order to solve the current situation of single clinical treatment mode and poor effect of diabetes, the applicant, based on the extensive research results of mesenchymal stem cell treatment of diseases, innovatively introduced GLP-1 and FGF21 into autologous adipose mesenchymal stem cells, such as 201810283803.0 and 202010180799.2, to obtain a cell therapy product for type 2 diabetes.
[0003] In order to explore the safety, efficacy and stability evaluation system of cell therapy products for the treatment of type 2 diabetes mellitus modified with autologous adipose-derived mesenchymal stem cells with dual GLP-1 and FGF21, it is necessary to develop a method for detecting the copy number of the target gene in adipose-derived stem cells with high expression of the dual GLP-1 and FGF21 that has good specificity and repeatability. Summary of the invention
[0004] The present invention targets autologous adipose-derived mesenchymal stem cells modified by the dual factors of GLP-1 and FGF21, uses the regulatory element WPRE sequence carried by the target gene as the target gene detection site, and the internal reference gene ALB as the cell detection site, and has high specificity and strong repeatability for the detection of sample gene copy number, thereby completing the present invention.
[0005] The purpose of the present invention is to provide a method for detecting the copy number of a target gene in adipose stem cells with high expression of both GLP-1 and FGF21. The method uses the regulatory element WPRE sequence carried by the target gene as the target gene detection site and the internal reference gene ALB as the cell detection site.
[0006] The inventors have found that the regulatory element WPRE sequence is carried by the target gene and is highly specific, stable and reliable as a target gene detection site, which is also confirmed by the test results.
[0007] ALB (albumin) is a human albumin gene, a single copy gene located on the long arm of chromosome 4, and is stably present in human cells. The inventors have found that using it as an internal reference gene for detection has strong repeatability and high stability.
[0008] In the method of the present invention, the qPCR method can be used to quantitatively detect the WPRE and ALB genes, and then the copy number of the target gene in the adipose stem cell sample with high expression of both GLP-1 and FGF21 factors can be obtained by calculation.
[0009] Among them, as a qPCR method, it is preferable to use the Taqman probe method.
[0010] In the present invention, as primers for the WPRE sequence, primers commonly used in the art can be used, and there is no particular limitation on this. However, preferably, one or more pairs of the following primers are used:
[0011] Primer Pair 101:
[0012] Upstream primer: 5'-CCTTTCCGGGACTTTCGCTTT-3'
[0013] Downstream primer: 5′-GCAGAATCCAGGTGGCAACA-3′;
[0014] Primer pair 102:
[0015] Upstream primer: 5'-ACTGTGTTTGCTGACGCAAC-3'
[0016] Downstream primer: 5′-AAGGAAGGTCCGCTGGATTG-3′;
[0017] Primer pair 103:
[0018] Upstream primer: 5'-CAGCTCCTTTCCGGGACTTT-3'
[0019] Downstream primer: 5′-GGACGATGATTTCCCCGACA-3′;
[0020] Primer pair 104:
[0021] Upstream primer: 5'-CACCACCTGTCAGCTCCTTT-3'
[0022] Downstream primer: 5′-ACGGAATTGTCAGTGCCCAA-3′;
[0023] Primer pair 105:
[0024] Upstream primer: 5'-TTGGGCACTGACAATTCCGT-3'
[0025] Downstream primer: 5′-CCGAAGGGACGTAGCAGAAG-3′;
[0026] Primer pair 106:
[0027] Upstream primer: 5'-CGCTTTCCCCCTCCCTATTG-3'
[0028] Downstream primer: 5′-CACCACGGAATTGTCAGTGC-3′;
[0029] Primer pair 107:
[0030] Upstream primer: 5'-CGCTATGTGGATACGCTGCT-3'
[0031] Downstream primer: 5′-GTTGCGTCAGCAAACACAGT-3′;
[0032] Primer pair 108:
[0033] Upstream primer: 5'-CTTTCCCCCTCCCTATTGCC-3'
[0034] Downstream primer: 5′-CGGAATTGTCAGTGCCCAAC-3′;
[0035] Primer pair 109:
[0036] Upstream primer: 5'-CTTCTGCTACGTCCCTTCGG-3'
[0037] Downstream primer: 5′-AAGGGAGATCCGACTCGTCT-3′;
[0038] Primer pair 110:
[0039] Upstream primer: 5'-CAATCCAGCGGACCTTCCTT-3'
[0040] Downstream primer: 5′-AGATCCGACTCGTCTGAGGG-3′;
[0041] Primer pair 111:
[0042] Upstream primer: 5'-GCACTGACAATTCCGTGGTG-3'
[0043] Downstream primer: 5′-GAAGGTCCGCTGGATTGAGG-3′;
[0044] More preferably, primer pair 101 is used:
[0045] Upstream primer: 5'-CCTTTCCGGGACTTTCGCTTT-3'
[0046] (WPRE-FP1)
[0047] Downstream primer: 5'-GCAGAATCCAGGTGGCAACA-3'
[0048] (WPRE-RP1).
[0049] In a preferred embodiment of the method of the present invention, as the WPRE sequence probe, a probe selected from the following is used:
[0050] 5'-FAM-ACTCATCGCCGCCTGCCTTGCC-BHQ1-3';
[0051] 5'-FAM-ATTGCCACCACCTGTCAGCTCCTTT-BHQ1-3';
[0052] 5'-FAM-TGCCACGGCGGAACTCATCGCCGCC-BHQ1-3';
[0053] 5'-FAM-CGGAACTCATCGCCGCCTGCCTTGC-BHQ1-3';
[0054] 5'-FAM-CTTTCCTTGGCTGCTCGCCTGTGTT-BHQ1-3';
[0055] 5'-FAM-CGCCGCCTGCCTTGCCCGCTGCTGG-BHQ1-3';
[0056] 5'-FAM-TGCCACCACCTGTCAGCTCCTTCC-BHQ1-3';
[0057] 5'-FAM-GCCTGCCTTGCCCGCTGCTGGACAG-BHQ1-3';
[0058] 5'-FAM-TCCTTCCCGCGGCCTGCTGCCGGCT-BHQ1-3';
[0059] 5'-FAM-TGCTGCCGGCTCTGCGGCCTCTTCC-BHQ1-3';
[0060] 5'-FAM-CTCGCCTGTGTTGCCACCTGGATTC-BHQ1-3';
[0061] More preferably use:
[0062] 5'-FAM-ACTCATCGCCGCCTGCCTTGCC-BHQ1-3'(WPRE-P1).
[0063] In the qPCR (Taqman probe) method, as primers for the ALB gene, primers commonly used in the art can be used, and there is no particular limitation on this. However, preferably, one or more pairs of the following primers are used:
[0064] Primer pair 201:
[0065] Upstream primer: 5'-TGAAACATACGTTCCCAAAGAGTTT-3'
[0066] Downstream primer: 5′-CTCTCCTTCTCAGAAAGTGTGCATAT-3′;
[0067] Primer pair 202:
[0068] Upstream primer: 5'-GGGGTGTGTTTCGTCGAGAT-3'
[0069] Downstream primer: 5′-TGTTTTGCACAGCAGTCAGC-3′;
[0070] Primer pair 203:
[0071] Upstream primer: 5'-ACCTAGGAAAAGTGGGCAGC-3'
[0072] Downstream primer: 5′-CTGAAAAGCATGGTCGCCTG-3′;
[0073] Primer pair 204:
[0074] Upstream primer: 5'-ATGACAACCCAAACCTCCCC-3'
[0075] Downstream primer: 5′-GAAATCTCTGGCTCAGGCGA-3′;
[0076] Primer pair 205:
[0077] Upstream primer: 5'-CAGGCGACCATGCTTTTCAG-3'
[0078] Downstream primer: 5′-GTTGCCTTGGGCTTGTGTTT-3′;
[0079] Primer pair 206:
[0080] Upstream primer: 5'-CCTGTTGCCAAAGCTCGATG-3'
[0081] Downstream primer: 5′-GAGCTGAAAAGCATGGTCGC-3′;
[0082] Primer pair 207:
[0083] Upstream primer: 5'-CTCGGCTTATTCCAGGGGTG-3'
[0084] Downstream primer: 5′-CTCTGGTCTCACCAATCGGG-3′;
[0085] Primer pair 208:
[0086] Upstream primer: 5'-CCCGATTGGTGAGACCAGAG-3'
[0087] Downstream primer: 5′-TATACTTGGCAAGGTCCGCC-3′;
[0088] Primer pair 209:
[0089] Upstream primer: 5'-GCGACCATGCTTTTCAGCTC-3'
[0090] Downstream primer: 5′-GCGACCATGCTTTTCAGCTC-3′;
[0091] Primer pair 210:
[0092] Upstream primer: 5'-GCACACAAGAGTGAGGTTGC-3'
[0093] Downstream primer: 5′-AGGCAATCAACACCAAGGCT-3′;
[0094] Primer pair 211:
[0095] Upstream primer: 5'-GAGTGAGGTTGCTCATCGGT-3'
[0096] Downstream primer: 5′-GCATTCCGTGTGGACTTTGG-3′;
[0097] More preferably, primer pair 201:
[0098] Upstream primer: 5'-TGAAACATACGTTCCCAAAGAGTTT-3' (ALB-F)
[0099] Downstream primer: 5'-CTCTCCTTCTCAGAAAGTGTGCATAT-3' (ALB-R).
[0100] In a preferred embodiment of the method of the present invention, as the probe of the internal reference gene ALB, a probe selected from the following is used:
[0101] 5'-HEX-TGCTGAAACATTCACCTTCCATGCAGA-BHQ1-3';
[0102] 5'-HEX-ATCGGTTTAAAGATTTGGGAGAAGA-BHQ1-3';
[0103] 5'-HEX-ATGCCCTGTGCAGAAGACTATCTAT-BHQ1-3';
[0104] 5'-HEX-GTGATGTGCACTGCTTTTCATGACA-BHQ1-3';
[0105] 5'-HEX-ATATGCACACTTTCTGAGAAGGAGA-BHQ1-3';
[0106] 5'-HEX-CGTCTGCCAAACAGAGACTCAAGTG-BHQ1-3';
[0107] 5'-HEX-CTGCACTTGTTGAGCTCGTGAAACA-BHQ1-3';
[0108] 5'-HEX-TTATATGAAATTGCCAGAAGACATC-BHQ1-3';
[0109] 5'-HEX-CATACGTTCCCAAAGAGTTTAATGC-BHQ1-3';
[0110] 5'-HEX-GATTGCCTTTGCTCAGTATCTCAG-BHQ1-3';
[0111] 5'-HEX-ATTTCAAAGCCTTGGTGTTGATTGC-BHQ1-3';
[0112] More preferably use:
[0113] 5'-HEX-TGCTGAAACATTCACCTTCCATGCAGA-BHQ1-3'(ALB-P).
[0114] In the method of the present invention, the process of the qPCR (Taqman probe) method includes: for the GLP-1 and FGF21 dual-factor high-expressing adipose stem cells to be detected, diluting the dilution (RNase-Free H2O) and the negative cell sample, amplifying 2 replicate wells, diluting the extracted sample genome, preferably to 20 ng / μl, performing multiple, preferably 3 parallel repeatability tests, and calculating the CV value between multiple, such as 3 parallel measurement results. DETAILED DESCRIPTION
[0115] The present invention is further described below by way of examples. However, it should be understood by those skilled in the art that the examples are only used to illustrate the present invention and do not constitute any limitation to the present invention.
[0116] In the verification implementation of the method of the present invention, the (positive) cells used are autologous adipose-derived mesenchymal stem cells with high expression of both GLP-1 and FGF21, which are autologous adipose-derived mesenchymal stem cells with high expression of both GLP-1 and FGF21 provided by the applicant's prior patent 201810283803.0, see "Examples 1 and 2" for details.
[0117] Example 1
[0118] Unless otherwise specified, the experiments and methods described in the examples were performed in accordance with conventional methods well known in the art and described in various references. If no specific conditions are specified in the examples, the experiments were performed according to conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used without indicating the manufacturer are all conventional products that can be obtained commercially.
[0119] 1. Main instruments and equipment
[0120]
[0121]
[0122] 2. Main reagents and consumables
[0123]
[0124]
[0125] Overview: Test diluent (RNase-Free H2O) and extracted negative cell (unmodified cell) samples, amplify 2 replicates, dilute the extracted sample genome to 20 ng / μl, perform 3 parallel repeatability tests, and calculate the CV value between the 3 parallel measurement results.
[0126] 1. Sample Extraction
[0127] (1) Take 2×10 6 Cells, 300rcf, centrifuge for 5min. Take 200μl PBS buffer to resuspend the cell pellet, take a new 1.5ml EP tube and add 200μl PBS buffer as the negative extraction control NCS. Add 20μl Proteinase K and 200μl Buffer AL to each EP tube, vortex for 10s to mix, and incubate at 56℃ for 10min. After the reaction is completed, centrifuge for 10s to remove the liquid on the tube cap;
[0128] (2) Remove the sample, add 200 μl of anhydrous ethanol to each tube, vortex and shake for 10 seconds to mix, centrifuge briefly, transfer the resulting mixture to a QIAamp Mini centrifuge column (attached to a 2 ml collection tube), centrifuge at 6000 rcf for 1 min, and discard the filtrate;
[0129] (3) Add 500 μl Buffer AW1, centrifuge at 20,000 rcf for 1 min, and discard the filtrate;
[0130] (4) Add 500 μl Buffer AW2, centrifuge at 20,000 rcf for 3 min, and discard the filtrate;
[0131] (5) Transfer the QIAamp Mini centrifuge column to a new 2 ml collection tube and centrifuge at 20,000 rcf for 1 min.
[0132] (6) Transfer the QIAamp Mini centrifuge column to a new 1.5 ml EP tube and leave it uncovered for 2–3 min to allow the remaining ethanol to evaporate.
[0133] (7) Add 100 μl of elution buffer AE and centrifuge at 6000 rcf for 1 min. The resulting solution is the purified gDNA solution.
[0134] (8) Take 2 μl of purified gDNA solution, adjust the baseline to 0 with Buffer AE, and determine the DNA content and A260 / A280 purity according to the "UV5Nano Ultraviolet Visible Spectrophotometer Manual". If the OD value is between 1.8 and 2.0, it is judged that the extracted sample meets the requirements; dilute the sample gDNA to 20 ng / μl.
[0135] 2.qPCR detection
[0136] 2.1 Reagent preparation
[0137] (1) Primer probe dilution: Take out the primer probe, centrifuge at room temperature at 5000 rcf / 5 min, dilute the primer probe concentration to 10 μM with nuclease-free water according to the tube wall information, and then dispense. Primer 100 μl / tube, probe 50 μl / tube, mark the primer information on the tube wall, such as primer name, concentration, and dispensing date. Store the dispensed primer probe in a -20℃ refrigerator.
[0138] (2) Preparation of standard: Take the plasmid standard and dilute it to 1×10 with TE Buffer. 9 The samples were divided into copies / μl for standby use, 15μl / tube, and 10-fold gradient dilution was performed according to the table below before each experiment.
[0139]
[0140]
[0141] 2.2 Experimental process
[0142] (1) Prepare qPCR mixture according to the following table
[0143]
[0144]
[0145] (2) After the reaction solution is prepared, vortex it for 5-10 seconds to mix thoroughly, then centrifuge it. Add 25 μl of the reaction solution to each well in the PCR reaction tube and cover the reaction cap.
[0146] (3) Add 5 μl Nuclease-Free Water (NTC), 5 μl negative control NCS extract and 5 μl sample gDNA to the PCR reaction solution, and cover the reaction cap.
[0147] (4) Add 5 μl of each concentration standard to the PCR reaction solution and cover the reaction cap.
[0148] Add sample to each reaction well
[0149]
[0150] (4) Centrifuge the reaction mixture for 10-20 seconds.
[0151] (5) Set up the QPCR program: Refer to the "Roche Real-time Fluorescence Quantitative PCR Instrument Operation and Maintenance Manual" to set the parameters and template, and select DuaL CoLor HydroLysis Probe / UPL Probe (FAM / VIC)
[0152]
[0153] 3. Results Summary
[0154]
[0155]
[0156] Among them, UND-not detected
[0157]
[0158] The results showed that: (1) the diluent (RNase-Free H2O) had no interference, and the detection results of negative cells were negative, and its Cp average was greater than the Cp average of the lowest point of the calibration curve; (2) the CV value between the three parallel determination results of the sample was ≤30.0%.
[0159] Based on the above research results, this method is suitable for the detection of the copy number of the target gene in adipose stem cells with high expression of GLP-1 and FGF21 dual factors.
[0160] Example 2
[0161] Reagents
[0162]
[0163]
[0164] Instruments and Equipment
[0165]
[0166] 2.1 Exclusivity
[0167] Purpose: Verify the ability of the analytical method to correctly determine the substance being tested even in the presence of other components (such as impurities, degradation products, excipients, etc.), or that the method specifically detects the substance being tested and cannot be detected when negative substances are present.
[0168] Experimental Design :Take 2~5×10 6 After extracting the negative cells (NC) of each cell, dilute the DNA to 20ng / μl and test 2 replicates. Take 180μl of preparation buffer for extraction and amplification, and test 2 replicates. Use the plasmid standard ST4 as the positive control PC and the sample diluent (EASY Dilution) and Nuclease-Free Water for qPCR detection, and test 2 replicates.
[0169] Acceptable Standards :The negative cells and preparation buffer are extracted and tested, and the Cp average of the test results WPRE is greater than the Cp value of the lowest point of the standard curve. ST4 is used as the positive control PC, and its Cp value of the test results should be within the range of the standard curve. The Cp average of the test results WPRE of the amplification sample diluent (EASY Dilution) and Nuclease-Free Water is greater than the Cp value of the lowest point of the standard curve.
[0170] result :
[0171]
[0172] in conclusion :The test results of negative cells, preparation buffer, sample diluent (EASY Dilution), and Nuclease-Free Water showed that the Cp average of WPRE was greater than the Cp value of the lowest point of the standard curve, and there was no interference with the test. Using ST4 as a positive control, the Cp value of its test results was within the range of the standard curve. The above specificity investigation results all met the acceptance criteria.
[0173] 2.2 Accuracy
[0174] Purpose : Verification refers to the degree to which the results measured by the established method are close to the true value or reference value to ensure the accuracy of the method's test results.
[0175] Experimental design: The extracted sample DNA was diluted to 20 ng / μl with EASY Dilution, and three concentrations (5×106 copies / μl, 1×10 6 copies / μl, 1×10 5Each concentration was prepared in triplicate and tested in duplicate. The preparation process is shown in the following table.
[0176]
[0177]
[0178] Acceptable Standards :The recoveries of the samples at different spiked concentrations were all between 70.0% and 130.0%, with CV≤30.0% (n=3).
[0179] result :
[0180]
[0181]
[0182] in conclusion: The recoveries of the samples with different spike concentrations were all between 70.0% and 130.0%, and the CV was ≤ 30.0% (n = 3). This result met the acceptance criteria for accuracy.
[0183] 2.3 Precision
[0184] Repeatability:
[0185] Purpose Evaluation method: Under specified measurement conditions, the degree of closeness between the results obtained by multiple sampling and measurement of the same uniform test product is expressed by relative standard deviation CV.
[0186] Experimental design : Experimenter 1 conducted the experiment on D1 (first day) and extracted 6 samples independently in parallel, named S1, S2, S3, S4, S5, and S6 respectively. After extraction, the DNA was diluted for qPCR detection.
[0187] Acceptable Standards : The copy number detection results of 6 parallel samples were CV≤30.0% (n=6).
[0188] result:
[0189]
[0190]
[0191]
[0192] in conclusion: The copy number detection results of 6 parallel samples were CV 3.98% ≤ 30.0% (n = 6). The repeatability verification results met the acceptance criteria.
[0193] Intermediate precision
[0194] Purpose : Investigate the precision between the results measured by different operators at different times, and the degree of closeness between the results obtained after multiple sampling and measurement, expressed as relative standard deviation CV.
[0195] Experimental design : Experimenter 2 conducted the experiment on D2 (different day) and extracted 6 samples independently in parallel, named S7, S8, S9, S10, S11, and S12 respectively. After extraction, the DNA was diluted for qPCR detection.
[0196] Acceptable Standards : Experimenter 1 and experimenter 2 tested the copy number of 12 parallel samples and the results showed that CV was ≤30.0% (n=12).
[0197] result
[0198]
[0199]
[0200]
[0201] in conclusion : The copy number detection results of 12 parallel samples tested by experimenter 1 and experimenter 2 were CV 10.59%≤30.0% (n=12). The intermediate precision verification results met the acceptance criteria.
[0202] 2.4 Limit of quantitation
[0203] Purpose : Investigate the lowest concentration that can accurately quantify the vector copy number in the sample.
[0204] Experimental design : The plasmid standard was diluted to 100 copies / μl using EASY Dilution and named S13. Six parallel preparations were made.
[0205] serial number dilution copies / μl 1E9 15μl / tube <![CDATA[1×10 9 ]]> 1E8 10μl(1E9)+90μl(EASY Dilution) <![CDATA[1×10 8 ]]> ST1 10μl(1E8)+90μl(EASY Dilution) <![CDATA[1×10 7 ]]> ST2 10μl(ST1)+90μl(EASY Dilution) <![CDATA[1×10 6 ]]> ST3 10μl(ST2)+90μl(EASY Dilution) <![CDATA[1×10 5 ]]> ST4 10μl(ST3)+90μl(EASY Dilution) <![CDATA[1×10 4 ]]> ST5 10μl(ST4)+90μl(EASY Dilution) <![CDATA[1×10 3 ]]> ST6 10μl(ST5)+90μl(EASY Dilution) <![CDATA[1×10 2 ]]> S13 10μl(ST5)+90μl(EASY Dilution) <![CDATA[1×10 2 ]]>
[0206] Acceptable Standards :The recovery rate is between 70.0% and 130.0%, and the CV is ≤30.0% (n=6). This concentration is the limit of quantification.
[0207] result :
[0208]
[0209]
[0210] in conclusion :The recovery rate was between 70.0% and 130.0%, and CV ≤ 30.0% (n = 6), which met the quantitative limit acceptance criteria. The quantitative limit of this detection method was 1 × 10 2 copies / μl.
[0211] 2.4 Linear range
[0212] Purpose : Linear range refers to the upper and lower limits or quantity interval of the measurement method when a certain precision, accuracy and linearity can be achieved. The linearity of the kit is confirmed by evaluating the standard curve.
[0213] Experimental design : Dilute the plasmid standard to 1×10 using EASY Dilution. 7 copies / μl, 1×10 6 copies / μl, 1×10 5 copies / μl, 1×10 4 copies / μl, 1×10 3 copies / μl and 1×10 2 The linearity test results refer to the results of three sets of standard curves for accuracy, precision and durability.
[0214] Acceptable Standards : R of the standard curve 2 ≥0.99, amplification efficiency is within 90.0%~110.0%. It meets the requirements of precision, accuracy, limit of quantification and linear relationship.
[0215] result:
[0216]
[0217]
[0218] in conclusion : R of three sets of standard curves 2 ≥0.99, amplification efficiency is within 90.0%~110.0%. Linearity verification results meet the acceptance criteria. The highest spike concentration in the accuracy verification experiment is 5×10 6The spiked recovery rate of WPRE (FAM) detection was 87.5% and the CV value was 6.81% for 10 copies / μl, and the spiked recovery rate of ALB (VIC) detection was 75.8% and the CV value was 3.40%. 2 The recovery rate of WPRE (FAM) detection of 1000 copies / μl was 92.9%, and the CV value was 7.01%. The spiked recovery rate of ALB (VIC) detection was 100.1%, and the CV value was 9.60%. The requirements of precision, accuracy, quantitative limit and linear relationship were met. Therefore, the detection range of this detection method is: 1×10 2 copies / μl~5×10 6 copies / μl.
[0219] 2.5 Durability
[0220] Purpose :The degree to which the measurement results will not be affected when there are small changes in the measurement conditions, providing a basis for the established method to be used for routine inspection.
[0221] Experimental design : Configure two experimental reaction plates with three parallel samples of accuracy S1, S2, and S3 and load them on the machine at different times (immediately and after being placed at 2-8°C for more than 1 hour).
[0222] Acceptable Standards : The detection results of gene copy number amplified at different times had a CV≤30.0% (n=6).
[0223] result
[0224]
[0225] in conclusion : The gene copy number detection results of amplification at different times CV≤30.0% (n=6). The durability verification results meet the acceptance criteria.
[0226] In summary, the specificity, accuracy, repeatability, intermediate precision, limit of quantification, linearity, range and durability of the method of the present invention were verified, and the verification data all met the acceptance criteria and passed the verification, indicating that the method is suitable for the detection of the copy number of the target gene in adipose stem cells with high expression of GLP-1 and FGF21 dual factors.
[0227] The present invention has been described in detail above in conjunction with specific implementations and exemplary examples, but these descriptions cannot be understood as limiting the present invention. Those skilled in the art understand that, without departing from the spirit and scope of the present invention, a variety of equivalent substitutions, modifications or improvements may be made to the technical solution of the present invention and its implementation methods, all of which fall within the scope of the present invention. The scope of protection of the present invention shall be subject to the attached claims.
Claims
1. A method for detecting the copy number of a target gene in adipose stem cells with high expression of both GLP-1 and FGF21. The method uses the regulatory element WPRE sequence carried by the target gene as the target gene detection site and the internal reference gene ALB as the cell detection site.
2. The method according to claim 1, wherein the quantitative detection is performed by real-time fluorescence quantitative PCR.
3. The method according to claim 1, wherein the real-time fluorescence quantitative PCR method is a Taqman probe method.
4. The method according to claim 1, wherein one or more pairs of the following primers are used as primers for the WPRE sequence: Primer Pair 101: Upstream primer: 5'-CCTTTCCGGGACTTTCGCTTT-3' Downstream primer: 5′-GCAGAATCCAGGTGGCAACA-3′; Primer pair 102: Upstream primer: 5'-ACTGTGTTTGCTGACGCAAC-3' Downstream primer: 5′-AAGGAAGGTCCGCTGGATTG-3′; Primer pair 103: Upstream primer: 5'-CAGCTCCTTTCCGGGACTTT-3' Downstream primer: 5′-GGACGATGATTTCCCCGACA-3′; Primer pair 104: Upstream primer: 5'-CACCACCTGTCAGCTCCTTT-3' Downstream primer: 5′-ACGGAATTGTCAGTGCCCAA-3′; Primer pair 105: Upstream primer: 5'-TTGGGCACTGACAATTCCGT-3' Downstream primer: 5′-CCGAAGGGACGTAGCAGAAG-3′; Primer pair 106: Upstream primer: 5'-CGCTTTCCCCCTCCCTATTG-3' Downstream primer: 5′-CACCACGGAATTGTCAGTGC-3′; Primer pair 107: Upstream primer: 5'-CGCTATGTGGATACGCTGCT-3' Downstream primer: 5′-GTTGCGTCAGCAAACACAGT-3′; Primer pair 108: Upstream primer: 5'-CTTTCCCCCTCCCTATTGCC-3' Downstream primer: 5′-CGGAATTGTCAGTGCCCAAC-3′; Primer pair 109: Upstream primer: 5'-CTTCTGCTACGTCCCTTCGG-3' Downstream primer: 5′-AAGGGAGATCCGACTCGTCT-3′; Primer pair 110: Upstream primer: 5'-CAATCCAGCGGACCTTCCTT-3' Downstream primer: 5′-AGATCCGACTCGTCTGAGGG-3′; Primer pair 111: Upstream primer: 5'-GCACTGACAATTCCGTGGTG-3' Downstream primer: 5′-GAAGGTCCGCTGGATTGAGG-3′.
5. The method according to claim 1, wherein the primer pair 101 is used as a primer for the WPRE sequence: Upstream primer: 5'-CCTTTCCGGGACTTTCGCTTT-3' Downstream primer: 5′-GCAGAATCCAGGTGGCAACA-3′.
6. The method according to claim 1, wherein as the WPRE sequence probe, a probe selected from the following is used: 5'-FAM-ACTCATCGCCGCCTGCCTTGCC-BHQ1-3'; 5'-FAM-ATTGCCACCACCTGTCAGCTCCTTT-BHQ1-3'; 5'-FAM-TGCCACGGCGGAACTCATCGCCGCC-BHQ1-3'; 5'-FAM-CGGAACTCATCGCCGCCTGCCTTGC-BHQ1-3'; 5'-FAM-CTTTCCTTGGCTGCTCGCCTGTGTT-BHQ1-3'; 5'-FAM-CGCCGCCTGCCTTGCCCGCTGCTGG-BHQ1-3'; 5'-FAM-TGCCACCACCTGTCAGCTCCTTCC-BHQ1-3'; 5'-FAM-GCCTGCCTTGCCCGCTGCTGGACAG-BHQ1-3'; 5'-FAM-TCCTTCCCGCGGCCTGCTGCCGGCT-BHQ1-3'; 5'-FAM-TGCTGCCGGCTCTGCGGCCTCTTCC-BHQ1-3'; 5'-FAM-CTCGCCTGTGTTGCCACCTGGATTC-BHQ1-3'; Preferred use: 5'-FAM-ACTCATCGCCGCCTGCCTTGCC-BHQ1-3'.
7. The method according to claim 1, wherein one or more pairs of the following primers are used as primers for the ALB gene: Primer pair 201: Upstream primer: 5'-TGAAACATACGTTCCCAAAGAGTTT-3' Downstream primer: 5′-CTCTCCTTCTCAGAAAGTGTGCATAT-3′; Primer pair 202: Upstream primer: 5'-GGGGTGTGTTTCGTCGAGAT-3' Downstream primer: 5′-TGTTTTGCACAGCAGTCAGC-3′; Primer pair 203: Upstream primer: 5'-ACCTAGGAAAAGTGGGCAGC-3' Downstream primer: 5'-CTGAAAAGCATGGTCGCCTG-3'; Primer pair 204: Upstream primer: 5'-ATGACAACCCAAACCTCCCC-3' Downstream primer: 5'-GAAATCTCTGGCTCAGGCGA-3'; Primer pair 205: Upstream primer: 5'-CAGGCGACCATGCTTTTCAG-3' Downstream primer: 5'-GTTGCCTTGGGCTTGTGTTT-3'; Primer pair 206: Upstream primer: 5'-CCTGTTGCCAAAGCTCGATG-3' Downstream primer: 5'-GAGCTGAAAAGCATGGTCGC-3'; Primer pair 207: Upstream primer: 5'-CTCGGCTTATTCCAGGGGTG-3' Downstream primer: 5'-CTCTGGTCTCACCAATCGGG-3'; Primer pair 208: Upstream primer: 5'-CCCGATTGGTGAGACCAGAG-3' Downstream primer: 5'-TATACTTGGCAAGGTCCGCC-3'; Primer pair 209: Upstream primer: 5'-GCGACCATGCTTTTCAGCTC-3' Downstream primer: 5'-GCGACCATGCTTTTCAGCTC-3'; Primer pair 210: Upstream primer: 5'-GCACACAAGAGTGAGGTTGC-3' Downstream primer: 5′-AGGCAATCAACACCAAGGCT-3′; Primer pair 211: Upstream primer: 5'-GAGTGAGGTTGCTCATCGGT-3' Downstream primer: 5′-GCATTCCGTGTGGACTTTGG-3′.
8. The method according to claim 1, wherein the primer pair 201 is used as the primer for the ALB gene: Upstream primer: 5'-TGAAACATACGTTCCCAAAGAGTTT-3' Downstream primer: 5′-CTCTCCTTCTCAGAAAGTGTGCATAT-3′.
9. The method according to claim 1, wherein as the probe of the internal reference gene ALB, a probe selected from the following is used: 5'-HEX-TGCTGAAACATTCACCTTCCATGCAGA-BHQ1-3'; 5'-HEX-ATCGGTTTAAAGATTTGGGAGAAGA-BHQ1-3'; 5'-HEX-ATGCCCTGTGCAGAAGACTATCTAT-BHQ1-3'; 5'-HEX-GTGATGTGCACTGCTTTTCATGACA-BHQ1-3'; 5'-HEX-ATATGCACACTTTCTGAGAAGGAGA-BHQ1-3'; 5'-HEX-CGTCTGCCAAACAGAGACTCAAGTG-BHQ1-3'; 5'-HEX-CTGCACTTGTTGAGCTCGTGAAACA-BHQ1-3'; 5'-HEX-TTATATGAAATTGCCAGAAGACATC-BHQ1-3'; 5'-HEX-CATACGTTCCCAAAGAGTTTAATGC-BHQ1-3'; 5'-HEX-GATTGCCTTTGCTCAGTATCTTCAG-BHQ1-3'; 5'-HEX-ATTTCAAAGCCTTGGTGTTGATTGC-BHQ1-3'; Preferred use: 5'-HEX-TGCTGAAACATTCACCTTCCATGCAGA-BHQ1-3'.
10. The method of claim 3, wherein the Taqman probe method comprises: For the GLP-1 and FGF21 dual-factor high-expressing adipose stem cells to be tested, their dilution (RNase-Free H2O) and negative cell samples were amplified in duplicate wells, the extracted sample genome was diluted, and multiple, parallel repeatability tests were performed to calculate the CV values between multiple parallel measurement results.
